Latest AI and machine learning research in prescriptions for healthcare professionals.
Pharmaceutical industry and the art and science of drug development are sorely in need of novel transformative technologies in the current age of digital health and artificial intelligence (AI). Often described as game-changing technologies, AI and machine learning algorithms have slowly but surely begun to revolutionize pharmaceutical industry and drug development over the past 5 years. In this e...
The aim of this study was to describe interventions for PARO, as well as the outcomes evaluated and found following use of PARO, and to identify outcome measures in PARO intervention studies for older adults with dementia. Multiple databases (Web of Science, PubMed, Cumulative Index to Nursing and Allied Health Literature, EMBASE, Cochrane, and Scopus) were searched and eight studies were included...
Despite recent advances in cancer treatment, developing better therapeutic reagents remains an essential task for oncologists. To accurately character...
Social media has been identified as a promising potential source of information for pharmacovigilance. The adoption of social media data has been hind...
OBJECTIVE: Motivated by the well documented worldwide spread of adverse drug events, as well as the increased danger of antibiotic resistance (caused ...
There is significant interest in the development and application of deep neural networks (DNNs) to neuroimaging data. A growing literature suggests th...
Building automated cancer screening systems based on image analysis is currently a hot topic in computer vision and medical imaging community. One of ...
Tumor subclass detection and diagnosis is inevitable requirement for personalized medical treatment and refinement of the effects that the somatic cel...
Fast identification of microbial species in clinical samples is essential to provide an appropriate antibiotherapy to the patient and reduce the presc...
In this work, an ontology-based model for AI-assisted medicine side-effect (SE) prediction is developed, where three main components, including the dr...
Drug-associated adverse events cause approximately 30 billion dollars a year of added health care expense, along with negative health outcomes includi...
Drug-drug interactions are critical in studying drug side effects. Thus, quickly and accurately identifying the relationship between drugs is necessar...
Named Entity Recognition (NER) in the healthcare domain involves identifying and categorizing disease, drugs, and symptoms for biosurveillance, extrac...
Motor fluctuations are a frequent complication in patients with Parkinson's disease (PD) where the response to medication fluctuates between ON states...
Despite the presence of methods evaluating drug resistance during chemotherapies, techniques, which allow for monitoring the degree of drug resistance...
Recent progress on bioresorbable and bio-compatible miniature systems provides prospects for developing novel nanorobots operating inside the human bo...
Thrombotic events are one of the leading causes of mortality and morbidity related to cancer, with ovarian cancer having one of the highest incidence ...
In the field of pervasive computing, wearable devices have been widely used for recognizing human activities. One important area in this research is t...
This work presents a two-stage deep learning system for Named Entity Recognition (NER) and Relation Extraction (RE) from medical texts. These tasks ar...
Due to the massive data sets available for drug candidates, modern drug discovery has advanced to the big data era. Central to this shift is the devel...